These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6173370)

  • 1. Drug sensitivity and some characteristics of a bleomycin-resistant subline of mouse lymphoblastoma L5178Y cells.
    Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1210-2. PubMed ID: 6173370
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of membrane-associated enzymes in drug-resistant sublines of mouse lymphoblastoma L5178Y cells.
    Sugimoto Y; Nishimura T; Suzuki H; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1200-5. PubMed ID: 6173369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.
    Suzuki H; Sugimoto Y; Tanaka K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):602-9. PubMed ID: 6547433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake and efflux of peplomycin in sensitive and bleomycin-resistant subline of mouse lymphoblastoma L5178Y cells.
    Ozawa S; Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1988 Mar; 41(3):395-7. PubMed ID: 2452818
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to androgen in murine lymphosarcoma lines resistant or sensitive to glucocorticoid hormone.
    Sasson S; Mayer M
    Br J Cancer; 1981 Jul; 44(1):127-8. PubMed ID: 6894859
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.
    Nishimura T; Suzuki H; Muto K; Tanaka N
    J Antibiot (Tokyo); 1979 May; 32(5):518-22. PubMed ID: 583339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of adriamycin or N-trifluoroacetyladriamycin-14-valerate on a mouse lymphoma.
    Potmesil M; Levin M; Traganos F; Israel M; Darzynkiewicz Z; Khetarpal VK; Silber R
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):109-22. PubMed ID: 6602051
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
    Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
    Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of drug-resistant tumor progression.
    Mironova N; Shklyaeva O; Andreeva E; Popova N; Kaledin V; Nikolin V; Vlassov V; Zenkova M
    Ann N Y Acad Sci; 2006 Dec; 1091():490-500. PubMed ID: 17341638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on an acid ribonuclease from corticoid-sensitive 9alpha-fluoroprednisolone-treated lymphosarcoma P1798: changes in heat inactivation kinetics of the enzyme due to steroid treatment.
    Biswas S; Hollander VP
    Cancer Res; 1970 Mar; 30(3):827-9. PubMed ID: 5468048
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells.
    Nishimura T; Muto K; Tanaka N
    J Antibiot (Tokyo); 1978 May; 31(5):493-5. PubMed ID: 670093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of action and resistance of antineoplastic agents].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of antineoplastic antibiotics using a rapid method of evaluating their cytostatic effect on tumor cells].
    Volkolupova OP; Makukho LV
    Antibiot Khimioter; 1989 Mar; 34(3):213-5. PubMed ID: 2751378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Free radicals in the tissue of sarcomas].
    Petiaev MM; Reznikov SA; Cherepneva IE; Siusina TG; Tereshchenko TV
    Vopr Onkol; 1967; 13(9):108-12. PubMed ID: 4300278
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
    Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid vesicle (liposome) encapsulation of methotrexate on its chemotherapeutic efficacy in solid rodent tumors.
    Kosloski MJ; Rosen F; Milholland RJ; Papahadjopoulos D
    Cancer Res; 1978 Sep; 38(9):2848-53. PubMed ID: 581069
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin-induced DNA synthesis in a cell-free system using a permeable mouse sarcoma cell extract.
    Seki S; Mori S; Oda T
    Acta Med Okayama; 1987 Oct; 41(5):195-9. PubMed ID: 2446466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.